IP Library › Assignment 039391/0585
Patent Assignment
Reel/Frame 039391/0585

Corrective Assignment to Correct the Spelling of the Receiving Party Name Previously Recorded on Reel 039005 Frame 0001. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2016-07-19 Pages: 12
Assignor
TABUTEAU, HERRIOT
Executed: 2016-06-14
Assignee
ANTECIP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties (12)
Methods of Modulating Drug Plasma Levels Using Erythrohydroxybupropion
Patent: 9,402,844 →
Application: 14/628,062 →
Publication: US US20150157582A1
Treatment of Complex Regional Pain Syndrome Using Denosumab
Patent: 9,371,392 →
Application: 14/952,724 →
Publication: US US20160075791A1
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Patent: 9,370,513 →
Application: 14/978,976 →
Publication: US US20160136155A1
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Application: 15/055,386 →
Publication: US US20160175333A1
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Application: 15/164,651 →
Publication: US US20160263134A1
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Patent: 9,457,023 →
Application: 15/164,746 →
Publication: US US20160263099A1
Compositions Comprising Rank/Rankl Antagonists and Related Compounds for Treating Pain
Patent: 9,493,571 →
Application: 15/182,378 →
Publication: US US20160289330A1
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Patent: 9,474,731 →
Application: 15/182,253 →
Publication: US US20160317476A1
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Patent: 9,700,528 →
Application: 15/164,767 →
Publication: US US20160263100A1
Pharmaceutical Compositions Comprising Meloxicam
Patent: 9,821,075 →
Application: 15/132,130 →
Publication: US US20160228576A1
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Application: 15/188,725 →
Publication: US US20160296539A1
Pharmaceutical Compositions Comprising Meloxicam
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 6, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 035980/0996 →
Assignment of Assignor's Interest Dec 28, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 037368/0114 →
Assignment of Assignor's Interest Dec 28, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 037367/0457 →
Assignment of Assignor's Interest Jun 24, 2016
From: TABUTEAU, HERRIOT
To: ANTICEP BIOVENTURES II LLC
Reel/Frame 039005/0001 →
Corrective Assignment to Correct the Spelling of the Assignee's Name on the Coversheet Previously Recorded at Reel: 039005 Frame: 0001. Assignor(S) Hereby Confirms the Assignment. Jun 29, 2016
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 039206/0481 →
Assignment of Assignor's Interest Jul 7, 2016
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 039103/0203 →
Assignment of Assignor's Interest Sep 21, 2017
From: ANTECIP BIOVENTURES II LLC
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 043657/0690 →
Assignment of Assignor's Interest Dec 8, 2017
From: TABUTEAU, HERRIOT
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 044343/0453 →
Intellectual Property Security Agreement Sep 25, 2020
From: AXSOME THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 053941/0491 →
Security Interest May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Release of Security Interest May 22, 2025
From: HERCULES CAPITAL, INC.
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 071337/0004 →